The Global Blood
Dialyzer Market, by Product Type (Reusable and Disposable), by Dialysis
Membrane Material (Cellulose Membranes and Synthetic Membranes), by End User
(Hospitals, Ambulatory Surgical Centers, Home Care Settings, and Specialty
Clinics), was valued at US$ 4,682.7 million in 2017, and is projected to
exhibit a CAGR of 6.1%, during the forecast period (2018 - 2026).
Dialysis is a treatment done on
patients at later stage of kidney failure (chronic renal insufficiency). This
treatment is achieved by using an assembly called dialyzers, which cleans blood
and removes wastes and excess fluid from the body that are normally removed by
healthy kidneys. In hemodialysis, blood is removed from the body and circulated
through an extracorporeal fluid circuit (outside the body), then returned to
the body. Hemodialyzer encloses a selectively permeable membrane acting as a
filter that allows fluids and waste materials to pass through. Increasing incidence
of chronic kidney diseases is expected to increase the number of dialysis
process, which in turn will fuel growth of the blood dialyzers market during
the forecast period. For instance, according to the Global Kidney Health Atlas
April 2017, one in three people in the general population is at increased risk
of chronic kidney diseases and an estimated 10% of people worldwide, had
chronic kidney disease (CKD) in 2017. Furthermore, the estimates suggest that 9
in 10 of those suffering from CKD are unacquainted of their condition.
Browse 23 Market Data Tables and
19 Figures spread through 157 Pages and in-depth TOC on "Blood Dialyzer
Market, by Product Type (Reusable, and Disposable), by Dialysis Membrane
Material (Cellulose Membranes, and Synthetic Membranes), by End User
(Hospitals, Ambulatory Surgical Centers, Home Care Settings, and Specialty
Clinics) - Global Forecast to 2026"
* The sample copy includes:
Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report
Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2503
Manufacturers are engaged in
intensifying its services by expanding manufacturing units, and joint ventures.
For instance, in December 2017, Nikkiso Co. Ltd. of Japan partnered with China
based, Shandong Weigao Group Medical Polymer Company, to increase production of
dialyzers in China by fivefold by 2020, and raise its output to 20,000 units
every year. Furthermore, key players are focusing on new product launches to
maximize access to end users for its products and in turn increase its market
share. For instance, in September 2016, B. Braun Medical Inc., launched xevonta
kidney dialyzer, following 501(k) clearance by the FDA. This dialyzer will be
available in the U.S. market. Xevonta kidney dialyzer's innovative membrane
technology was intended to improve clearance performance by removing more
toxins from patients’ blood. Also, in May 2017, NxStage Medical, Inc. received
clearance from FDA for the next generation hemodialysis system. It consists of
new features and capabilities, including a touchscreen user interface and
integrated blood pressure monitor designed to enhance ease of use for patients
to perform home hemodialysis. Moreover, rising government initiatives to
advance improved treatment options for patients with kidney failure aids
manufacturers to gain substantial growth in the global blood dialyzer market.
For instance, in September 2018,
the U.S. Department of Health and Human Services (HHS) and the American Society
of Nephrology (ASN) held a prize money of US $ 2,265,000 for KidneyX: Redesign
Dialysis. This competition challenges manufacturers to develop better treatment
options for patients with kidney failure. Thus, HHS is expecting innovations in
the field of dialysis and dialyzer membranes to redesign treatment for kidney
failure.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/blood-dialyzer-market-2503
Key Takeaways of the Blood
Dialyzer Market:
The global blood dialyzer market
is expected to expand at a CAGR of 6.1% during the forecast period (2018 –
2026), owing to continuous technological advancements in dialyzers membrane.
Based on product type, disposable
dialyzers are expected to receive maximum growth, owing to risks associated
with reusable dialyzers.
On the basis of dialysis membrane
material, synthetic cellulose segment is expected to perceive maximum traction
owing to new product launches. For instance, in November 2017, Nipro Medical
Corporation announced the launch of Cellentia-H cellulose triacetate (CTA), a
single-use dialyzer at the 2017 ASN Kidney Week Conference. The cellulose
triacetate membrane optimizes excellent biocompatibility and clearances to
minimize potential adverse reactions. The Cellentia-H is also gamma sterilized
to enhance product safety and sterility. Such technology advancements in blood
dialyzers promote its growth in the global market during the forecast period.
Major players operating in the
global blood dialyzer market include Baxter International, Inc., Nikkiso Co.
Ltd., B. Braun Medical Inc., Nipro Corporation, CVS Health., Diaverum
Deutschland GmbH, NxStage Medical, Inc., Fresenius Medical Care AG & Co.
KGaA, and DaVita Healthcare Partners, Inc.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2503
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment